ClinVar Miner

Submissions for variant NM_014244.5(ADAMTS2):c.2900G>A (p.Arg967His)

dbSNP: rs775213299
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV001245934 SCV001419259 uncertain significance Ehlers-Danlos syndrome, dermatosparaxis type 2021-08-31 criteria provided, single submitter clinical testing This sequence change replaces arginine with histidine at codon 967 of the ADAMTS2 protein (p.Arg967His). The arginine residue is highly conserved and there is a small physicochemical difference between arginine and histidine. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals affected with ADAMTS2-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Fulgent Genetics, Fulgent Genetics RCV001245934 SCV002806173 uncertain significance Ehlers-Danlos syndrome, dermatosparaxis type 2021-12-14 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.